EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model

Ko, 2015, Progress in the treatment of metastatic pancreatic cancer and the search for next opportunities, J Clin Oncol, 33, 1779, 10.1200/JCO.2014.59.7625 Li, 2015, Pancreatic cancer: diagnosis and treatments, Tumour Biol, 36, 1375, 10.1007/s13277-015-3223-7 Lowery, 2015, Novel therapeutics for pancreatic adenocarcinoma, Hematol Oncol Clin North Am, 29, 777, 10.1016/j.hoc.2015.04.006 Bria, 2007, Gemcitabine-based combinations for inoperable pancreatic cancer: have we made real progress? A meta-analysis of 20 phase 3 trials, Cancer, 110, 525, 10.1002/cncr.22809 Pollom, 2015, Treatment approaches to locally advanced pancreatic adenocarcinoma, Hematol Oncol Clin North Am, 29, 741, 10.1016/j.hoc.2015.04.005 Rubinson, 2015, Therapeutic approaches for metastatic pancreatic adenocarcinoma, Hematol Oncol Clin North Am, 29, 761, 10.1016/j.hoc.2015.04.012 Seicean, 2015, New targeted therapies in pancreatic cancer, World J Gastroenterol, 21, 6127, 10.3748/wjg.v21.i20.6127 Sirohi, 2015, Advances in chemotherapy for pancreatic cancer, Indian J Surg Oncol, 6, 47, 10.1007/s13193-014-0371-y Neesse, 2011, Stromal biology and therapy in pancreatic cancer, Gut, 60, 861, 10.1136/gut.2010.226092 Wachtel, 2008, Pancreas cancer survival in the gemcitabine era, Clin Med Oncol, 2, 405 Olive, 2009, Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer, Science, 324, 1457, 10.1126/science.1171362 Gillen, 2010, Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages, PLoS Med, 7, e1000267, 10.1371/journal.pmed.1000267 Conroy, 2011, FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer, N Engl J Med, 364, 1817, 10.1056/NEJMoa1011923 Kundranda, 2015, Albumin-bound paclitaxel in solid tumors: clinical development and future directions, Drug Des Devel Ther, 9, 3767, 10.2147/DDDT.S88023 Kommareddy, 2005, Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione, Bioconjug Chem, 16, 1423, 10.1021/bc050146t Kommareddy, 2007, Poly(ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery, Nanomedicine, 3, 32, 10.1016/j.nano.2006.11.005 Kommareddy, 2007, Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancer-bearing mice, J Pharm Sci, 96, 397, 10.1002/jps.20813 Kommareddy, 2008, Cell transfection and analysis using DNA-loaded gelatin nanoparticles Kommareddy, 2008, Preparation and loading of gelatin nanoparticles Xu, 2012, Therapeutic gene delivery and transfection in human pancreatic cancer cells using epidermal growth factor receptor-targeted gelatin nanoparticles, J Vis Exp, 59, e3612 Xu, 2013, Biodistribution and pharmacokinetics of EGFR-targeted thiolated gelatin nanoparticles following systemic administration in pancreatic tumor-bearing mice, Mol Pharm, 10, 2031, 10.1021/mp400054e Xu, 2014, Redox-responsive targeted gelatin nanoparticles for delivery of combination wt-p53 expressing plasmid DNA and gemcitabine in the treatment of pancreatic cancer, BMC Cancer, 14, 75, 10.1186/1471-2407-14-75 Mazur, 2012, Genetically engineered mouse models of pancreatic cancer: unravelling tumour biology and progressing translational oncology, Gut, 61, 1488, 10.1136/gutjnl-2011-300756 Kim, 2009, Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice, Nat Protoc, 4, 1670, 10.1038/nprot.2009.171 Schutte, 2011, Recent developments of transgenic and xenograft mouse models of pancreatic cancer for translational research, Exp Opin Drug Discov, 6, 33, 10.1517/17460441.2011.534453 Drake, 2005, Assessing tumor growth and distribution in a model of prostate cancer metastasis using bioluminescence imaging, Clin Exp Metastasis, 22, 674, 10.1007/s10585-006-9011-4 Navarro, 1999, Changes in glutathione status and the antioxidant system in blood and in cancer cells associate with tumour growth in vivo, Free Radic Biol Med, 26, 410, 10.1016/S0891-5849(98)00213-5 Quah, 2010, The use of carboxyfluorescein diacetate succinimidyl ester (CFSE) to monitor lymphocyte proliferation, J Vis Exp, 44, 2259